Around 100,000 Australians live with myelofibrosis, which is a rare form of blood cancer. Treating the condition is difficult - anaemia is a common side effect. But an Australian-developed drug - just approved by the Therapeutic Goods Administration - is helping patients overcome some of the cancer's worst symptoms.